Refined chromosome study helps define prognostic subgroups in most patients with primary myelodysplastic syndrome and acute myelogenous leukaemia.

Source:http://linkedlifedata.com/resource/pubmed/id/3162379

Download in:

View as

General Info

PMID
3162379